Articles related to CLINICAL STUDY

N=1 science empowers patients to become “citizen scientists,” experimenting and refining their health choices to find what works best for their own bodies.

Improper arm positioning during blood pressure measurement can lead to overestimations of up to 7 mmHg in systolic pressure, potentially altering patient diagnoses and treatment plans.

A meta-analysis of 99 randomized controlled trials suggests that vitamin D supplementation may offer significant cardiometabolic benefits, with the greatest improvements seen in specific population subgroups.

A randomized controlled trial involving 108 adults with metabolic syndrome found that implementing an 8- to 10-hour time-restricted eating window, in addition to standard-of-care treatments, resulted in a 0.10% reduction in HbA1c levels compared to standard care alone.

A prospective study involving over 170,000 participants from the UK Biobank found that moderate coffee consumption (3 drinks/day) was associated with a 48.1% lower risk of developing cardiometabolic multimorbidity compared to non-consumers.

Recent research comparing SGLT2 inhibitors and dulaglutide in older patients with type 2 diabetes suggests a potential difference in dementia risk. The study estimated a risk ratio of 0.81 (CI, 0.56 to 1.16) for SGLT2 inhibitors compared to dulaglutide.